Editorial - Hematology and Blood Disorders (2021) Volume 4, Issue 4

Editorial note on molecular genetics and pathophysiology.

Xenahu Weng^*

Department of Oncology, Zengzhou University, Beijing, China

Corresponding Author:

Xenahu Weng
Department of Oncology
Zengzhou University
Beijing
China
E-mail: xena_wng6@163.com

Accepted date: August 31, 2021

Citation: Weng X. Editorial note on molecular genetics and pathophysiology. Hematol Blood Disord 2021;4(4):16.

Editorial Note

I am pleased to mention that during the year 2021, all issues of volume 4 were published online well within the time and the print issues were also brought out and dispatched within 45 days of publishing the issue online.

Research and reviews

Hematology and Blood Disorders journal is an scholarly Open Access journal that aims to publish the foremost complete and reliable source of data on discoveries and current developments within the mode of original articles, review articles, case reports, short communications, etc. altogether areas of the sector, making them freely available online to the researchers worldwide with none subscriptions The Journal is using Editorial Manager System for quality in online manuscript submission, review and tracking. Editorial board members of

Research and Reviews:

Outside experts review manuscripts; a minimum of two independent reviewer’s approval followed by the editor is required for the acceptance of manuscripts.

Scope of the journal

Hematology and Blood Disorders journal has published articles related anemias, leukemias, blood clotting disorders, multiple myeloma, lymphocytic disorders, immune system disorders, blood count disorders, stem cell disorders, transfusion medicine, hematology, thrombocytopenia, thalassemias, Hodgkins lymphoma, Non-Hodgkin’s lymphoma, red cell biology, immunobiology, hemobiology, bone marrow transplantation, acute myeloid leukemia.

Google analytics

According to the Google Analytics, readers are visiting to our journal websites for submitting manuscripts, to browse the latest research published on public Hematology and Blood Disorders journal. Most of the papers are from USA, Italy Marine and Aquatic biology is more. Average publication of paper will be 45 days and after accepting the paper will be under per reviewed process for 21 days, then the accepting paper or article will takes 7 days for publication. We develop this journal for awareness and to help many peoples and students about Hematology study at different level of techniques to treat diseases, different types of diseases and prevention.

The coming year we are going to publish the articles related haematological studies, molecular genetics, pathophysiology, etiology, epidemiology, prevention, diagnosis and management of blood disorders.

As of today’s society, the utilization of social media has become a necessary daily activity, it's a valuable tool locally and worldwide, so we'll communicate with the Researchers, Students, Scholars, Scientists, Professors, Deans, Institutes, Universities, and every one the members associated with the topic through LinkedIn, Twitter, Face book, My Live Chart, WhatsApp. We post the upcoming Issue and Journal highlights and current research works in social networks. in order that all the members can work on the research and submit their papers.

I take this opportunity to acknowledge the contribution of authors during the final editing of articles published and the support rendered by the editorial assistant in bringing out issues of Hematology and Blood Disorders journal in time. I would also like to express my gratitude to all the authors, reviewers, the publisher, the advisory and the editorial board of Hematology and Blood Disorders journal, the office bearers and staff for their support in bringing out yet another volume of Hematology and Blood Disorders journal and look forward to their unrelenting support to bring out the of Hematology and Blood Disorders journal in scheduled time.